Literature DB >> 27992893

The efficacy and safety of ECT in population before and after 60 years of age.

Anna Antosik-Wójcińska1, Łukasz Święcicki1.   

Abstract

OBJECTIVES: The aim of the study was to evaluate efficacy and safety of electroconvulsive therapy (ECT), in two age groups: before and after 60 years of age.
METHODS: The study included 107 patients, 62 women and 45 men hospitalized in the Institute of Psychiatry and Neurology and treated with ECT in 2013 and 2014. 76 people were below 60 years; 31 people - above 60. The authors analyzed the course of 1086 ECTs, 747 sessions for patients before 60 and 339 in patients over 60 years of age. The efficacy of ECT was diagnosed using CGI Scale.
RESULTS: No serious complications such as death, life-threatening condition, hospitalization in another ward or permanent injury occurred. In 67.11% of patients below 60 and 42% of patients after 60 years of age no side effects were observed. Below 60 years of age most frequently reported adverse reactions were headaches (13.16% of patients), above 60 years of age - memory impairment (22.58% of respondents). Arrhythmias occurred in 6 patients aged over 60. Disturbances of consciousness occurred among older patients slightly less frequently than in younger patients (3.25% vs. 3.95%). In patients over 60 years of age remission rate was similar as in younger age group (32.89% vs 32.26%) and significant improvement rate was even higher (61.29% over 60 vs. 48.68 before 60 years of age). No improvement of mental state occurred in 7.89% and worsening occurred in 2.63% of younger patients. All patients ged over 60 years benefited from the treatment.
CONCLUSIONS: The effectiveness of ECT in elderly was similar as in younger age group. The tolerance was slightly worse in patients aged over 60 years than in younger patients. The biggest problem in the elderly was not cognitive impairment, but the cardiovascular complications.

Entities:  

Keywords:  depression; electroconvulsive therapy; treatment effectiveness

Mesh:

Year:  2016        PMID: 27992893     DOI: 10.12740/PP/59104

Source DB:  PubMed          Journal:  Psychiatr Pol        ISSN: 0033-2674            Impact factor:   1.657


  4 in total

1.  Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study.

Authors:  Sarah H Lisanby; Shawn M McClintock; George Alexopoulos; Samuel H Bailine; Elisabeth Bernhardt; Mimi C Briggs; C Munro Cullum; Zhi-De Deng; Mary Dooley; Emma T Geduldig; Robert M Greenberg; Mustafa M Husain; Styliani Kaliora; Rebecca G Knapp; Vassilios Latoussakis; Lauren S Liebman; William V McCall; Martina Mueller; Georgios Petrides; Joan Prudic; Peter B Rosenquist; Matthew V Rudorfer; Shirlene Sampson; Abeba A Teklehaimanot; Kristen G Tobias; Richard D Weiner; Robert C Young; Charles H Kellner
Journal:  Am J Geriatr Psychiatry       Date:  2019-10-12       Impact factor: 4.105

2.  The incidence of prolonged post-electroconvulsive therapy delirium: A retrospective study.

Authors:  Sandeep Grover; Ajay Kumar; Subho Chakrabarti; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2020-03-17       Impact factor: 1.759

3.  Convulsive Status Epilepticus Induced by Electroconvulsive Therapy in a Patient with Major Depression.

Authors:  Emilie Wieben; Marianne Juel Kjeldsen; Claus H Sørensen
Journal:  Case Rep Psychiatry       Date:  2022-03-17

4.  Age-Associated Risk of Liver-Related Adverse Drug Reactions.

Authors:  Yan-Zhong Han; Yu-Ming Guo; Peng Xiong; Fei-Lin Ge; Jing Jing; Ming Niu; Xu Zhao; Zhao-Fang Bai; Hai-Bo Song; Xiao-He Xiao; Jia-Bo Wang
Journal:  Front Med (Lausanne)       Date:  2022-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.